Slide 1: Healthy organic growth, high profitability and strong cash flow
Healthy organic growth, high profitability and strong cash flow Getinge Q2 2026 Mattias Perjos, CEO Agneta Palmér, CFO
Slide 2: Key pillars for Getinge’s profitable growth journey
Key pillars for Getinge’s profitable growth journey Development for strategic KPIs Increase share from recurring revenue Increase sales share from high margin products1 Less field actions per Bn SEK Net sales Capital goods Recurring revenue Rest of Portfolio High margin products -53% 1,9 1,2 1,0 0,9
Slide 3: Key takeaways
Key takeaways Q2 2026 • Net sales grew by 4.6% organically and order intake increased by 6.2% organically • Healthy margins in the quarter - impacted by both tariff refund and underlying solid improvement • Strong cash flow and financial position 38,000 53 16 15.2 36,000 52 51.3 34,236 15 34,000 51
Slide 4: Key activities and events
Key activities and events Q2 2026 Offering and Customers Sustainability, Quality and other • Strong product launches: • 510(k) application submitted end of Q2 for Cardiosave (Intra- Aortic Balloon Pump) ‒ Aquadis Endo 110 (Automated endoscope reprocessing) • Product quality KPI continues to improve
Slide 5: Healthy organic topline growth – especially in Acute Care Therapies
Healthy organic topline growth – especially in Acute Care Therapies Order Intake and Net Sales Bridge Q2 2025 – Q2 2026 Order Intake Net Sales Organic Organic change +6.2% +20.8% +1.1% +6.2% change +6.0% -0.2% +4.3% +4.6% +3.7% 186 14 +1.7% 108 72 93 -22 8,361 8,668 8,238 8,381 SEK M SEK M Q2 2025 A
Slide 6: Margins strengthened by tariff refund and underlying improvements
Margins strengthened by tariff refund and underlying improvements Adjusted Gross Profit and EBITA Bridge Q2 2025 – Q2 2026 Adjusted Gross Profit Adjusted EBITA Adj GM,% Margin development Q2 2026 65.0 40.4 45.5 55.4 +4.8 pp Adj GP (Q2 2025) (58.0) (38.6) (43.6) (50.8) +1.1 pp Adj OPEX +0.2 pp D&A +1
Slide 7: Getinge continues to have a solid financial position
Getinge continues to have a solid financial position Strong FCF in quarter and good safety margin on leverage FCF positively impacted by improved operating profit… … and leverage continues to be well below 2.5x 1.7 1.6 1.7 1.5 1.5 1.2 1.0 0.8 1.7 1.6 1.5 1.5 1.7 0.8 0.5 (1.3x excl. pension liabiliti
Slide 8: Steady traction towards mid-term guidance span
Steady traction towards mid-term guidance span Halfway to end of 2028 and 0.8 pp remaining to span R12 Adj. EBITA margin 19 18 Mid-term guidance span of 16-19% adj. EBITA by end of 2028 17 16 +2.8 pp 15.5 15.0 15.2 15 Key levers: 14 ∆ Significant quality cost release, gradually from H2 2026 to 2028
Slide 9: Outlook 2026
Outlook 2026 Net sales for 2026 expected to increase by 3-5% organically* * Adjusted for the phase-out of Surgical Perfusion, which is expected to have net sales in 2026 declining from about 250 MSEK to 50 MSEK Getinge │ Presentation │ Q2 Report 2026 July 17, 2026 Page 9
Slide 10: Summary
Summary Getinge │ Presentation │ Q2 Report 2026 July 17, 2026 Page 10
Slide 11: Key takeaways
Key takeaways Summary Q2 2026 • Net sales grew by 4.6% organically and order intake increased by 6.2% organically • Healthy margins in the quarter - impacted by both tariff refund and underlying solid improvement • Strong cash flow and financial position • Outlook for 2026: organic net sales growth
Slide 12: Q&A
Q&A Getinge │ Presentation │ Q2 Report 2026 July 17, 2026 Page 12
Slide 13: Appendix – Equity story
Appendix – Equity story Getinge │ Presentation │ Q2 Report 2026 July 17, 2026 Page 13
Slide 14: World-leading Medtech at an inflection point
World-leading Medtech at an inflection point Quality cost release beginning H2 2026, the operational inflection is visible WHO WE ARE INVESTMENT CASE SHAREHOLDER RETURN #1-2 positions in core categories Visible margin recovery Prioritised dividend and healthy leverage Underlying improvement masked i
Slide 15: Thank you
Thank you Getinge │ Presentation │ Q2 Report 2026 July 17, 2026 Page 15
Slide 16: Forward-looking information
Forward-looking information This document contains forward-looking information based on the current expectations of Getinge’s management. Although management deems that the expectations presented by such forward-looking information are reasonable, no guarantee can be given that these expectations wi
Slide 17: Getinge – Passion for Life
“= Se A GETINGE PASSION FOR LIFE